Syngene International Ltd | Industry : (Healthcare) | |
---|---|---|
BSE Code : 539268 |
NSE Symbol : SYNGENE |
P/E(TTM) : 80.69 |
ISIN Demat : INE398R01022 |
Div & Yield% : 0.14 |
EPS(TTM) : 11.18 |
Book Value(₹) : 104.14 |
Market Cap(₹Cr) : 36,314.87 |
Face Value(₹) : 10.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 726.50 | 864.70 | 791.90 | 830.70 | 715.80 | 994.40 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 726.50 | 864.70 | 791.90 | 830.70 | 715.80 | 994.40 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 49.70 | 15.30 | 28.80 | 21.00 | 22.90 | 22.80 |
Total Income | 776.20 | 880.00 | 820.70 | 851.70 | 738.70 | 1,017.20 |
Total Expenditure | 578.30 | 565.40 | 596.10 | 621.50 | 552.40 | 678.00 |
PBIDT | 197.90 | 314.60 | 224.60 | 230.20 | 186.30 | 339.20 |
Interest | 7.40 | 8.50 | 6.30 | 8.60 | 6.10 | 10.40 |
PBDT | 190.50 | 306.10 | 218.30 | 221.60 | 180.20 | 328.80 |
Depreciation | 91.70 | 95.70 | 93.60 | 90.90 | 88.70 | 88.10 |
Tax | 17.20 | 41.50 | 19.10 | 22.80 | 16.40 | 42.10 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 7.70 | -20.90 | 5.80 | 6.30 | -0.20 | 9.60 |
Reported Profit After Tax | 73.90 | 189.80 | 99.80 | 101.60 | 75.30 | 189.00 |
Extra-ordinary Items | 23.94 | 0.00 | -2.96 | -5.75 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 49.96 | 189.80 | 102.76 | 107.35 | 75.30 | 189.00 |
EPS (Unit Curr.) | 1.84 | 4.73 | 2.49 | 2.53 | 1.88 | 4.71 |
EPS (Adj) (Unit Curr.) | 1.84 | 4.73 | 2.49 | 2.53 | 1.88 | 4.71 |
Calculated EPS (Unit Curr.) | 1.84 | 4.72 | 2.48 | 2.53 | 1.87 | 4.71 |
Calculated EPS (Adj) (Unit Curr.) | 1.84 | 4.72 | 2.48 | 2.53 | 1.87 | 4.71 |
Calculated EPS (Ann.) (Unit Curr.) | 7.34 | 18.89 | 9.93 | 10.11 | 7.49 | 18.83 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.34 | 18.89 | 9.93 | 10.11 | 7.49 | 18.83 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 402.50 | 402.00 | 402.00 | 402.00 | 402.00 | 401.40 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 27.24 | 36.38 | 28.36 | 27.71 | 26.03 | 34.11 |
PBDTM(%) | 26.22 | 35.40 | 27.57 | 26.68 | 25.17 | 33.07 |
PATM(%) | 10.17 | 21.95 | 12.60 | 12.23 | 10.52 | 19.01 |